Rhode Island Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rhode Island Hospital sits in the top decile of US sponsors by registered trial count (#210 of 15,742 sponsors by registered trial count).
Rhode Island Hospital: 130 sponsored US clinical trials, 26 recruiting.
Rhode Island Hospital sponsors 130 registered US clinical trials on ClinicalTrials.gov, 26 of them currently recruiting, and 93 completed. 14 of these trials are in Phase 3-4 (later-stage) and 34 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obsessive - Compulsive Disorder, with 3 trials.
Top-decile sponsor footprint
Rhode Island Hospital ranks in the top decile of sponsors by registered trial count (#210 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
93 of 101 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
130 total, page 2 of 3
The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU
NCT03931070
Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy
NCT03902314
Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools
NCT03446365
An Emotion Regulation Intervention for Early Adolescent Risk Prevention
NCT03430570
Effects of DHEA in Pulmonary Hypertension
NCT03648385
Rhode Island Asthma Integrated Response Program
NCT03583814
A Mobile Intervention to Improve Uptake of PrEP for Southern Black MSM
NCT03308097
The Navigator Trial
NCT03684681
A Sleep Hygiene Intervention to Improve Sleep Quality in Urban, Latino Middle School Children - Phase 1
NCT03717857
Bullying Prevention Intervention for Adolescent Primary Care Patients
NCT03467009
Implementing Alcohol Misuse SBIRT in a National Cohort of Pediatric Trauma Centers
NCT03297060
GAPcare: The Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department
NCT03360305
Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)
NCT03315533
Collar Use for Cervical Radicular Pain
NCT04163939
Restrictive Intravenous Fluids Trial in Sepsis
NCT03137446
GAPcare Fall Prevention Pilot Survey
NCT03076593
Improving Emotion Regulation Skills Among Adolescents Attempting to Lose Weight
NCT03393221
Skills to Enhance Positivity in Young Adults
NCT06621992
Biomarkers For Immune Checkpoint Inhibitors
NCT04204434
Digital Star: HIV Prevention for Youth in Mental Health Treatment
NCT02921841
Mobile Health Application to Improve HIV Medication Adherence
NCT02676128
A Computer-Based ED Intervention to Improve Pediatric Asthma Medicine Adherence
NCT02787174
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
NCT02602795
Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)
NCT02676544
Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)
NCT02725632
Women Engaging in Quitting Smoking Together
NCT02453659
A Multilevel Gaming Intervention for Persons on PrEP
NCT02611362
Text-Message-Based Depression Prevention for High-Risk Youth in the ED
NCT02332239
Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders
NCT02591446
CBT for Pediatric OCD: Community Training Pilot
NCT02202915
Emergency Department Home Blood Pressure Monitoring and BpTRU Study
NCT02217059
Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder
NCT02290899
Integrated Chronotherapy for Perinatal Depression
NCT02053649
Electronic Pre-visit Questionnaire to Prompt Discussions of Youth Violence in Primary Care
NCT02041182
Healing With Venlafaxine After Injury (HELP)
NCT01716377
Low Dose Ketamine for Management of Acute Severe Pain in the Emergency Department
NCT01740492
Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis
NCT01697059
A Pilot Gaming Adherence Program for Youth Living With HIV
NCT01887210
Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma
NCT01881412
Brief Intervention for Substance Use and Partner Abuse Among Females in the ER
NCT01709552
Pre-Release VIVITROL for Opioid Dependent Inmates
NCT01563718
Soft Tissue Ultrasound of Infections
NCT01557426
Smoking Cessation Intervention for Diabetic Patients
NCT01501877
Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
NCT01421485
Adaptation of the Pediatric Asthma Control & Communication Instrument (PACCI) in a Pediatric Emergency Department
NCT01895478
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
NCT01302444
Increasing Viral Testing in the Emergency Department
NCT01419899
Emergency Department (ED) Adolescent Alcohol Prevention Intervention
NCT01105416
Brief Intervention for Drug Misuse in the Emergency Department
NCT01124591
Bedside Ultrasound in the Diagnosis of Ankle Fractures in Children
NCT01341015
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 17 |
| Phase 2 | 17 |
| Phase 3 | 3 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Rhode Island Hospital pipeline
26 recruiting of 130 indexed (20% open); 93 completed (72%).
Phase mix: 14 late (III/IV) vs 34 early (I/II) (early-phase heavy).
Top condition: Obsessive - Compulsive Disorder (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rhode Island Hospital: open-pipeline peers nationwide
Peers matched on 130 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Rhode Island Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 130 trials (± recruiting share)
- National Institute on Aging (NIA) · 131 trials · 9% recruiting
- University of Illinois at Urbana-Champaign · 129 trials · 14% recruiting
- Jazz Pharmaceuticals · 128 trials · 12% recruiting
- George Washington University · 133 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Rhode Island Hospital page
130 registered trials is a research-attention snapshot, not an endorsement of Rhode Island Hospital or any single study.
- 26 of Rhode Island Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obsessive - Compulsive Disorder is the condition Rhode Island Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obsessive - Compulsive Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Rhode Island Hospital pipeline card: 130 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.